TY  - JOUR
AU  - Scarrott, Joseph M.
AU  - Herranz Martín, Saúl
AU  - Alrafiah, Aziza R.
AU  - Shaw, Pamela J.
AU  - Azzouz, Mimoun
PY  - 2015
DO  - 10.1517/14712598.2015.1044894
SN  - 1471-2598
SN  - 1744-7682
UR  - https://hdl.handle.net/20.500.14352/96283
T2  - Expert Opinion on Biological Therapy
AB  - Introduction: Amyotrophic lateral sclerosis (ALS) is a devastating adult neurodegenerative disorder characterized by motor neuron degeneration and death around 3 years from onset. So far, riluzole is the only treatment available, although it only...
LA  - eng
M2  - 935
PB  - Taylor and Francis Group
KW  - adeno-associated virus
KW  - amyotrophic lateral sclerosis
KW  - gene therapy
KW  - self-complementary adeno-associated virus serotype 9
TI  - Current developments in gene therapy for amyotrophic lateral sclerosis
TY  - journal article
VL  - 15
ER  -